QuantCapitol. Congressional Trading Intelligence

Updated nightly · Public disclosure record

← Newsroom

Roundup

Congressional trading brief — Nov 09 – Nov 16

Buying set the tone this week: of 74 newly disclosed trades, 39 were purchases and 35 were sales.

Buying set the tone this week: of 74 newly disclosed trades, 39 were purchases and 35 were sales. The selling concentrated in Technology — 7 sell disclosures there, more than any other sector.

One trade is worth a second look for who made it. Shelley Capito (Senate) disclosed selling $MSFT, $META and $AAPL while sitting on Senate Committee on Commerce, Science, and Transportation, whose remit runs through Technology. We point to the overlap because it belongs in the open — not because there is anything improper about it; many such overlaps are entirely ordinary.

It is tempting to assume these trades are winners; some are not. $FE has drifted back to around the $46.98 Newhouse first paid, $VNOM has drifted back to around the $42.41 Pfluger first paid and $DUFRY has drifted back to around the $5.71 Armstrong first paid — in each case with no sale disclosed since. On paper the gain has evaporated, which is the plainest argument against simply copying Congress: the entry is disclosed, the exit rarely is.

Every figure here is drawn from the official record. To see how late each trade was disclosed, browse the Leakage Index; for a custom sector audit or the raw data behind this brief, get in touch.

A financial disclosure is a public record filed under the STOCK Act, not evidence of wrongdoing. Amounts are reported as ranges, and any figures here are drawn from official filings. This is a transparency record, not investment advice.

Independent transparency record built from official congressional financial disclosures. Not affiliated with any member of Congress; not investment advice.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.